These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Natural killer cell mediated cytotoxicity against VERO target cells; the suppressive effect of pentoxifylline. Nagy Z; Mándi Y Immunol Lett; 1998 Sep; 63(2):121-3. PubMed ID: 9761374 [TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline therapy in HIV seropositive subjects with elevated TNF. Kruse A; Rieneck K; Kappel M; Orholm M; Bruunsgaard H; Ullum H; Skinhøj P; Pedersen BK Immunopharmacology; 1995 Nov; 31(1):85-91. PubMed ID: 8655293 [TBL] [Abstract][Full Text] [Related]
6. [Pentoxifylline]. Paradowski PT; Zeman K Postepy Hig Med Dosw; 1995; 49(2):201-20. PubMed ID: 8657627 [TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Neuner P; Klosner G; Pourmojib M; Knobler R; Schwarz T Immunology; 1997 Mar; 90(3):435-9. PubMed ID: 9155652 [TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline inhibits T-cell adherence to keratinocytes. Bruynzeel I; van der Raaij LM; Stoof TJ; Willemze R J Invest Dermatol; 1995 Jun; 104(6):1004-7. PubMed ID: 7539468 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules. Noel C; Copin MC; Hazzan M; Labalette M; Susen S; Lelievre G; Dessaint JP Transplantation; 2000 Mar; 69(6):1102-7. PubMed ID: 10762214 [TBL] [Abstract][Full Text] [Related]
10. Immune response modulation by pentoxifylline in vitro. Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042 [TBL] [Abstract][Full Text] [Related]
11. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. Barton MH; Moore JN; Norton N Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896 [TBL] [Abstract][Full Text] [Related]
12. Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes : a potential treatment for aseptic loosening of total joint components. Pollice PF; Rosier RN; Looney RJ; Puzas JE; Schwarz EM; O'Keefe RJ J Bone Joint Surg Am; 2001 Jul; 83(7):1057-61. PubMed ID: 11451976 [TBL] [Abstract][Full Text] [Related]
13. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells. Mizutani Y; Bonavida B; Nio Y; Yoshida O Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609 [TBL] [Abstract][Full Text] [Related]